Approvals/NMPA/Recombinant Human Papillomavirus Quadrivalent（Types 6,11,16,18）Vaccine（Hansenula polymorpha）

Approved

生物制品

Recombinant Human Papillomavirus Quadrivalent（Types 6,11,16,18）Vaccine（Hansenula polymorpha）

成都生物制品研究所有限责任公司🇨🇳 National Medical Products Administration

Approval Id: 8nJ9rHeXm1K
Approval Number: 国药准字S20250052
Generic Name: 四价人乳头瘤病毒疫苗(汉逊酵母)
Generic Name En: Recombinant Human Papillomavirus Quadrivalent（Types 6,11,16,18）Vaccine（Hansenula polymorpha）
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 每瓶0.5ml，每1次人用剂量为0.5ml，含HPV6型L1蛋白20μg、HPV11型 L1蛋白40μg、HPV16型 L1蛋白40μg、HPV18型 L1蛋白20μg。
Reg Date: 2025-09-23
Company Name: 成都生物制品研究所有限责任公司
Company Address: 四川省成都市锦江区锦华路三段379号
Production Company Name: 成都生物制品研究所有限责任公司
Production Company Address: 四川省成都市锦江区锦华路三段379号
Company Detail Path: /organization/cheng-du-sheng-wu-zhi-pin-yan-jiu-suo-you-xian-ze-ren-gong-si
Production Company Detail Path: /organization/cheng-du-sheng-wu-zhi-pin-yan-jiu-suo-you-xian-ze-ren-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 23, 2025

Approval ID

8nJ9rHeXm1K

Type

生物制品